Role of medicinal plants in the treatment of eumycetoma: A review

Mycetoma is a resultant infection of either fungi (eumycetoma) or bacteria (actinomycetoma). It is categorized under neglected tropical diseases, as it typically affects the economically backward communities of the endemic regions. The infection occurs with the invasion of etiological agents through the open wounds of the body. The cutaneous and subcutaneous tissue is characterized by the sinus formation and discharge. Primarily affecting the foot, it further spreads to other parts of the body. Eumycetoma has a worldwide distribution yet considered endemic, as it is restricted only to few countries. Diagnosis and treatment of the disease has been burdensome since poor response and unavailability of medical support in endemic regions. Microbiological and serological diagnostic methods have been unreliable except molecular diagnostics. Treatment with antifungal agents has given a mixed response, with only itraconazole being effective. These techniques are relatively expensive and cannot be afforded by people with weak economic background. In the context, it becomes essential to introduce phytotherapy to relieve the health and economic burden. Herein, we discuss few medicinal plants with profound antifungal activity towards eumycetoma. We highlight the possible course of actions that needs to be put forward to deliver the plant-based drugs to cure eumycetoma.

[1]  M. A. Mohamed,et al.  Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects , 2020, PLoS Neglected Tropical Diseases.

[2]  P. Fournier,et al.  Actinomycetoma Caused by Actinomadura mexicana, A Neglected Entity in the Caribbean , 2020, Emerging infectious diseases.

[3]  T. Boekhout,et al.  Madurella real-time PCR, a novel approach for eumycetoma diagnosis , 2020, PLoS neglected tropical diseases.

[4]  M. Shokri,et al.  Recurrent eumycetoma caused by novel species Madurella pseudomycetomatis: A case report , 2019, Medical mycology case reports.

[5]  Hassan,et al.  Boswellia and Commiphora Species as a Resource Base for Rural Livelihood Security in the Horn of Africa: A Systematic Review , 2019, Forests.

[6]  D. Soleša,et al.  Tea tree (Melaleuca alternifolia) and its essential oil: antimicrobial, antioxidant and acaricidal effects in poultry production , 2019, World's Poultry Science Journal.

[7]  B. Salehi,et al.  Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications , 2019, Molecules.

[8]  A. Jha,et al.  Mycetoma: reviewing a neglected disease , 2018, Clinical and experimental dermatology.

[9]  P. Balatti,et al.  Identification of an intermediate for 1,8-dihydroxynaphthalene-melanin synthesis in a race-2 isolate of Fulvia fulva (syn. Cladosporium fulvum) , 2018, Heliyon.

[10]  R. Hay,et al.  Mycetoma: The Spectrum of Clinical Presentation , 2018, Tropical medicine and infectious disease.

[11]  S. P. Dumre,et al.  Mycetoma: a clinical dilemma in resource limited settings , 2018, Annals of Clinical Microbiology and Antimicrobials.

[12]  A. Fahal,et al.  A holistic approach to the mycetoma management , 2018, PLoS neglected tropical diseases.

[13]  E. Reis-Filho,et al.  Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review* , 2018, Anais brasileiros de dermatologia.

[14]  B. Salehi,et al.  Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy , 2017, Molecules.

[15]  V. Garg,et al.  Mycetoma: An Update , 2017, Indian journal of dermatology.

[16]  A. Fahal,et al.  Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis , 2017, Tropical medicine & international health : TM & IH.

[17]  V. Kuete Other Health Benefits of African Medicinal Spices and Vegetables , 2017 .

[18]  A. Osman Functional Characteristics of Gum from Acacia Nubica , 2016 .

[19]  A. Fahal,et al.  Mycetoma Pulmonary Secondaries from a Gluteal Eumycetoma: An Unusual Presentation , 2016, PLoS neglected tropical diseases.

[20]  Y. Keum,et al.  Phytochemicals of Moringa oleifera: a review of their nutritional, therapeutic and industrial significance , 2016, 3 Biotech.

[21]  A. Nasr,et al.  Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients , 2016, PLoS neglected tropical diseases.

[22]  M. Goodfellow,et al.  Mycetoma: a unique neglected tropical disease. , 2016, The Lancet. Infectious diseases.

[23]  A. Fahal,et al.  Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  H. Verbrugh,et al.  A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study , 2015, PLoS neglected tropical diseases.

[25]  N. Hjira,et al.  Madura foot: Report of a eumycetoma Moroccan case , 2015 .

[26]  Wendy Kloezen,et al.  The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent , 2015, PLoS neglected tropical diseases.

[27]  S. Ehara,et al.  The “dot-in-circle” sign in musculoskeletal mycetoma on magnetic resonance imaging and ultrasonography , 2014, SpringerPlus.

[28]  A. Fahal,et al.  Mycetoma Medical Therapy , 2014, PLoS neglected tropical diseases.

[29]  A. Fahal,et al.  A New Model for Management of Mycetoma in the Sudan , 2014, PLoS neglected tropical diseases.

[30]  A. Bonifaz,et al.  Mycetoma: Experience of 482 Cases in a Single Center in Mexico , 2014, PLoS neglected tropical diseases.

[31]  M. Goodfellow,et al.  Merits and Pitfalls of Currently Used Diagnostic Tools in Mycetoma , 2014, PLoS neglected tropical diseases.

[32]  G. S. de Hoog,et al.  Madurella mycetomatis Is Highly Susceptible to Ravuconazole , 2014, PLoS neglected tropical diseases.

[33]  M. Goodfellow,et al.  The Mycetoma Knowledge Gap: Identification of Research Priorities , 2014, PLoS neglected tropical diseases.

[34]  W. V. D. van de Sande Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis , 2013, PLoS neglected tropical diseases.

[35]  L. Quintella,et al.  Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge* , 2013, Anais brasileiros de dermatologia.

[36]  A. Fahal,et al.  Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience , 2013, PLoS neglected tropical diseases.

[37]  Aftab Ahmad,et al.  A review on therapeutic potential of Nigella sativa: A miracle herb. , 2013, Asian Pacific journal of tropical biomedicine.

[38]  B. Stielow,et al.  Phylogenetic Findings Suggest Possible New Habitat and Routes of Infection of Human Eumyctoma , 2013, PLoS neglected tropical diseases.

[39]  A. Fahal,et al.  A Histopathological Exploration of the Madurella mycetomatis Grain , 2013, PloS one.

[40]  J. Meis,et al.  In Vitro Antifungal Activity of Isavuconazole against Madurella mycetomatis , 2012, Antimicrobial Agents and Chemotherapy.

[41]  M. Nicholson,et al.  A nodulo-cystic eumycetoma caused by Pyrenochaeta romeroi in a renal transplant recipient: A case report , 2011, Journal of medical case reports.

[42]  M. Z. Siddiqui Boswellia Serrata, A Potential Antiinflammatory Agent: An Overview , 2011, Indian journal of pharmaceutical sciences.

[43]  E. Zijlstra,et al.  The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  M. VAN DER BANK,et al.  The evolutionary history and biogeography of Mimosoideae (Leguminosae): an emphasis on African acacias. , 2010, Molecular phylogenetics and evolution.

[45]  N. Afroz,et al.  Eumycetoma versus actinomycetoma: Diagnosis on cytology , 2010, Journal of cytology.

[46]  A. van Belkum,et al.  Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents , 2010, Antimicrobial Agents and Chemotherapy.

[47]  F. Hao,et al.  Phenotypic and Molecular Characterization of Madurella pseudomycetomatis sp. nov., a Novel Opportunistic Fungus Possibly Causing Black-Grain Mycetoma , 2009, Journal of Clinical Microbiology.

[48]  A. Fahal,et al.  Mycetoma revisited. Incidence of various radiographic signs. , 2009, Saudi medical journal.

[49]  M. Asad,et al.  Anti-stress activity of hydro-alcoholic extract of Eugenia caryophyllus buds (clove) , 2009, Indian journal of pharmacology.

[50]  A. De Sarro,et al.  New and Investigational Triazole Agents for the Treatment of Invasive Fungal Infections , 2008, Journal of chemotherapy.

[51]  O. Kniemeyer,et al.  Production of Pyomelanin, a Second Type of Melanin, via the Tyrosine Degradation Pathway in Aspergillus fumigatus , 2008, Applied and Environmental Microbiology.

[52]  A. Bonifaz,et al.  Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases , 2008, The British journal of dermatology.

[53]  M. Ameen,et al.  Emerging therapeutic regimes for the management of mycetomas. , 2008, Expert opinion on pharmacotherapy.

[54]  D. Denning,et al.  New and emerging treatments for fungal infections. , 2008, The Journal of antimicrobial chemotherapy.

[55]  A. van Belkum,et al.  Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. , 2007, Microbes and infection.

[56]  A. van Belkum,et al.  In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. , 2007, The Journal of antimicrobial chemotherapy.

[57]  T. Riley,et al.  Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties , 2006, Clinical Microbiology Reviews.

[58]  A. Fahal Mycetoma: a thorn in the flesh. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[59]  A. van Belkum,et al.  Madurella mycetomatis Strains from Mycetoma Lesions in Sudanese Patients Are Clonal , 2003, Journal of Clinical Microbiology.

[60]  M. Brandt,et al.  Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi , 2003, Journal of chemotherapy.

[61]  A. van Belkum,et al.  Environmental Occurrence of Madurella mycetomatis, the Major Agent of Human Eumycetoma in Sudan , 2002, Journal of Clinical Microbiology.

[62]  A. Fahal The management of mycetoma. , 2010 .